Efficacy and Safety of Bimekizumab in Psoriatic Arthritis Patients with Significant Skin and Nail Involvement Over One Year - Poll - MDSpire

Efficacy and Safety of Bimekizumab in Psoriatic Arthritis Patients with Significant Skin and Nail Involvement Over One Year

  • By

  • Diamant Thaçi

  • Akihiko Asahina

  • Wolf-Henning Boehncke

  • Alice B. Gottlieb

  • Mark Lebwohl

  • Richard B. Warren

  • Heather Edens

  • Barbara Ink

  • Rajan Bajracharya

  • Jason Coarse

  • Joseph F. Merola

  • December 12, 2025

  • 0 min

Share

Original Source(s)

Efficacy and Safety of Bimekizumab in Psoriatic Arthritis Patients with Significant Skin and Nail Involvement Over One Year

  • by Diamant Thaçi, Akihiko Asahina, Wolf-Henning Boehncke, Alice B. Gottlieb, Mark Lebwohl, Richard B. Warren, Heather Edens, Barbara Ink, Rajan Bajracharya, Jason Coarse, Joseph F. Merola

  • December 12, 2025

Related Content

Efficacy and Safety of Deucravacitinib for Psoriasis: A Multicenter Real-World Analysis Focusing on Scalp Outcomes—IL PSO (Italian Landscape Psoriasis)

Paradoxical inflammatory switches during biologic therapy: a mechanistic framework, clinical algorithm, and pediatric illustrations

Cupping vs UVB: Comparable Psoriasis Outcomes?

Randomized study found no statistically significant differences in disease improvement between treatments over 8 weeks.